DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02563 BIOSTAR PHARM-B

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind
Major Shareholders Tang Li & Family (28.29%)
Tibet Xinsheng Deyuan Venture Capital Management Co., Ltd. (9.54%)
SDIC VC Fund (Shanghai) of Technology Transfer and Commercialization (Limited Partnership) (8.07%)
Cui Peng (7.68%)
Shanghai Haidai Botai Enterprise Management Centre (Limited Partnership) (6.71%)
Efung Investment Management Limited Partnership Enterprise (5.99%)
Zhuhai Huajin Haoyuan Enterprise Management Partnership (Limited Partnership) (5.27%)		 Sector Health Care & Biotechnology
Web Site http://www.biostar-pharm.com Tel N/A
Email N/A Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the research and development (‘‘R&D’’), manufacturing and sale of innovative drugs.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top